当前位置: X-MOL 学术Nat. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
When insulin isn’t enough: targeting glucagon in type 1 diabetes
Nature Medicine ( IF 58.7 ) Pub Date : 2022-10-03 , DOI: 10.1038/s41591-022-02019-3
Michelle Van Name 1 , Jennifer Sherr 1
Affiliation  

A phase 2 study fails to meet its primary endpoint, but the treatment — a glucagon receptor antagonist — shows clinically relevant improvements in glycemic control, warranting further investigation as a potential adjunct to insulin.

中文翻译:

当胰岛素不够时:针对 1 型糖尿病的胰高血糖素

一项 2 期研究未能达到其主要终点,但这种治疗——一种胰高血糖素受体拮抗剂——显示出临床相关的血糖控制改善,需要进一步研究作为胰岛素的潜在辅助手段。
更新日期:2022-10-04
down
wechat
bug